Download App
PAPER TRADE
Download App
Login
Feedback
VIVIMEDLAB
newsbot
Reputation: 200,298 •
May 10, 2021 6:06 PM
Vivimed Labs gets DGHS nod to manufacture, market Favipiravir tablets in India
Favipiravir is one of the leading oral anti-viral treatment approved in various countries for the potential treatment of patients with mild to moderate COVID-19 disease.
The Economic Times
https://economictimes.indiatimes.com/industry/healthcare/...
#VIVIMEDLAB
Vote
Comment
Share
NSE:VIVIMEDLAB price when posted: 29.2